Galmed Pharmaceuticals (GLMD) Change in Acquisitions & Divestments (2015 - 2025)

Galmed Pharmaceuticals' Change in Acquisitions & Divestments history runs 10 years deep, the most recent figure standing at $825000.0 for Q4 2025.

• In Q4 2025, Change in Acquisitions & Divestments fell 33.31% year-over-year to $825000.0; the TTM figure through Dec 2025 stood at $3.2 million (down 41.44% YoY), while the FY2025 annual figure was $1.6 million, down 70.73% from the prior year.
• Change in Acquisitions & Divestments was $825000.0 for Q4 2025 at Galmed Pharmaceuticals, down from $1.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $8.3 million in Q2 2023 to a low of -$750000.0 in Q1 2023.
• Historically, Change in Acquisitions & Divestments has averaged $2.1 million across 4 years, with a median of $1.2 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments tumbled 103.82% in 2023, then soared 678.04% in 2024.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at $5.6 million in 2022, then sank by 103.82% to -$214000.0 in 2023, then jumped by 678.04% to $1.2 million in 2024, then slumped by 33.31% to $825000.0 in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $825000.0 (Q4 2025), $1.2 million (Q4 2024), and $1.2 million (Q3 2024), per Business Quant data.